Longwood Fund

Longwood creates and invests in science-based companies that develop novel solutions for important medical problems.

Longwood Fund favicon
Founded 2010 ยท Venture Capital
Investment Stages
Series A
Series B
Markets
Healthcare
Biotech
Portfolio Companies

Evommune, Weaver, Xaira, Progentos, Bbot, Engrail, Doppler, Solu, AAVantgarde, DEM, Carbon, Photys, Rectify, Interius, Xylocor, Be Bio, Immunitas Therapeutics, Pyxis Oncology, Lassen Therapeutics, Werewolf, TScan, Archer, Sitryx, Bicycle Therapeutics, Grail, Pulmocide, Axial Therapeutics, Millendo Therapeutics, Channel Medsystems, Kalvista Pharmaceuticals, Colorescience, Calithera Biosciences, Mitobridge, Illuminoss, Verastem, PTC Therapeutics, Alnara

Share this page